Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 4
Submit an article Journal homepage
1,967
Views
2
CrossRef citations to date
0
Altmetric
Short Report

Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India

Sharad Agarkhedkara Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, Maharashtra, IndiaView further author information
,
Jugesh Chhatwalb Department of Pediatrics, Christian Medical College & Hospital, Ludhiana, Punjab, IndiaView further author information
,
Rajeev Zachariah Kompithrac Well Baby Immunization Clinic, Department of Pediatrics, Christian Medical College & Hospital, Vellore, Tamil Nadu, IndiaORCID Iconhttps://orcid.org/0000-0002-7678-8426View further author information
ORCID Icon,
Sanjay K. Lalwanid Department of Pediatrics, Medical College Road, Pune, Maharashtra, IndiaView further author information
,
Arun Narayane Department of Medicine, M.S. Ramaiah Medical College and Hospitals, Bangalore, IndiaView further author information
,
Vinay Muninarayanaswamf Department of Community Medicine, Mandya Institute of Medical Sciences, Mandya, Karnataka, IndiaView further author information
,
Nithya Gogtayg Department of Clinical Pharmacology, Seth GS Medical College & KEM Hospital, Mumbai, Maharashtra, IndiaView further author information
,
Kristin Dotterh Medical Operations, Sanofi Pasteur, Swiftwater, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9043-6646View further author information
ORCID Icon &
Viviane Gresset-Bourgeoisi Global Medical Strategy, Sanofi Pasteur, Lyon, FranceView further author information
 show all
Pages 973-977 | Received 19 Jul 2018, Accepted 26 Dec 2018, Published online: 12 Mar 2019

References

  • Venkatesh M, Doarn CR, Steinhoof M, Ying J. Assessment of burden of seasonal influenza in India and consideration of vaccination policy. Global J Med Public Health. 2016;5:1–10.
  • Mathew JL. Influenza vaccination for children in India. Indian Pediatr. 2009;46:304–07.
  • Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86:408–16.
  • Ministry of Health and Family Welfare DGoHSEMR. Seasonal influenza: Guidelines for vaccination with influenza vaccine. New Delhi, India: Ministry of Health & Family Welfare; 2017 [ accessed 2017 Nov 24]. https://mohfw.gov.in/sites/default/files/30580390001493710612.pdf.
  • Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology. 1990;175:59–68.
  • Crepey P, de Boer PT, Postma MJ, Pitman R. Retrospective public health impact of a quadrivalent influenza vaccine in the United States. Influenza Other Respir Viruses. 2015;9(Suppl 1):39–46. doi:10.1111/irv.12318.
  • Heikkinen T, Ikonen N, Ziegler T. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012. Clin Infect Dis. 2014;59:1519–24. doi:10.1093/cid/ciu664.
  • DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine. 2012;31:49–57. doi:10.1016/j.vaccine.2012.10.084.
  • Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT, Loeb M. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 2013;11:153. doi:10.1186/1741-7015-11-153.
  • Levandowski RA, Regnery HL, Staton E, Burgess BG, Williams MS, Groothuis JR. Antibody responses to influenza B viruses in immunologically unprimed children. Pediatrics. 1991;88:1031–36.
  • Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8:81–88. doi:10.4161/hv.8.1.17623.
  • Chadha MS, Potdar VA, Saha S, Koul PA, Broor S, Dar L, Chawla-Sarkar M, Biswas D, Gunasekaran P, Abraham AM, et al. Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing. PLoS One. 2015;10:e0124122. doi:10.1371/journal.pone.0124122.
  • Greenberg DP, Robertson CA, Noss MJ, Blatter MM, Biedenbender R, Decker MD. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults. Vaccine. 2013;31:770–76. doi:10.1016/j.vaccine.2012.11.074.
  • Greenberg DP, Robertson CA, Talbot HK, Decker MD. Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older. Hum Vaccin Immunother. 2017;13:2058–64. doi:10.1080/21645515.2017.1344375.
  • Greenberg DP, Robertson CA, Landolfi VA, Bhaumik A, Senders SD, Decker MD. Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age. Pediatr Infect Dis J. 2014;33:630–36. doi:10.1097/INF.0000000000000254.
  • Pepin S, Donazzolo Y, Jambrecina A, Salamand C, Saville M. Safety and immunogenicity of aquadrivalent inactivated influenza vaccine in adults. Vaccine. 2013;31:5572–78. doi:10.1016/j.vaccine.2013.08.069.
  • Sesay S, Brzostek J, Meyer I, Donazzolo Y, Leroux-Roels G, Rouzier R, Astruc B, Szymanski H, Toursarkissian N, Vandermeulen C, et al. Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial. Hum Vaccin Immunother. 2017;1–13. doi:10.1080/21645515.2017.1384106.
  • Cadorna-Carlos JB, Nolan T, Borja-Tabora CF, Santos J, Montalban MC, de Looze FJ, Eizenberg P, Hall S, Dupuy M, Hutagalung Y, et al. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial. Vaccine. 2015;33:2485–92. doi:10.1016/j.vaccine.2015.03.065.
  • Lalwani S, Chatterjee S, Balasubramanian S, Bavdekar A, Mehta S, Datta S, Povey M, Henry O. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial. BMJ Open. 2015;5:e007202. doi:10.1136/bmjopen-2014-007202.
  • Kompithra RZ, Sarkar R, Mathew LG, Muliyil J, Kang G. Study of common illnesses before and after vaccination: a risk interval approach. Indian Pediatr. 2015;52:933–38.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.